AU701247B2 - Vaccine and method for treatment of chlamydial infections - Google Patents

Vaccine and method for treatment of chlamydial infections Download PDF

Info

Publication number
AU701247B2
AU701247B2 AU11297/95A AU1129795A AU701247B2 AU 701247 B2 AU701247 B2 AU 701247B2 AU 11297/95 A AU11297/95 A AU 11297/95A AU 1129795 A AU1129795 A AU 1129795A AU 701247 B2 AU701247 B2 AU 701247B2
Authority
AU
Australia
Prior art keywords
momp
strains
chlamydia psittaci
ebs
sds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU11297/95A
Other languages
English (en)
Other versions
AU1129795A (en
Inventor
Marta Iris Sabara
James Evan Sandbulte
Julie Ann Terwee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of AU1129795A publication Critical patent/AU1129795A/en
Application granted granted Critical
Publication of AU701247B2 publication Critical patent/AU701247B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU11297/95A 1993-11-03 1994-11-02 Vaccine and method for treatment of chlamydial infections Ceased AU701247B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14763693A 1993-11-03 1993-11-03
US08/147636 1993-11-03
PCT/US1994/012626 WO1995012411A1 (fr) 1993-11-03 1994-11-02 Vaccin et procede de traitement contre les infections a chlamydia

Publications (2)

Publication Number Publication Date
AU1129795A AU1129795A (en) 1995-05-23
AU701247B2 true AU701247B2 (en) 1999-01-21

Family

ID=22522314

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11297/95A Ceased AU701247B2 (en) 1993-11-03 1994-11-02 Vaccine and method for treatment of chlamydial infections

Country Status (7)

Country Link
EP (1) EP0726775A4 (fr)
CN (1) CN1134112A (fr)
AU (1) AU701247B2 (fr)
BR (1) BR9407986A (fr)
CA (1) CA2175081A1 (fr)
NZ (1) NZ276874A (fr)
WO (1) WO1995012411A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2184132C (fr) * 1995-09-21 2011-03-15 Kristina J. Hennessy Vaccin avec adjuvant, pratiquement exempt d'albumine non-hote
US5972350A (en) * 1996-05-06 1999-10-26 Bayer Corporation Feline vaccines containing Chlamydia psittaci and method for making the same
US7459524B1 (en) 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
CA2336534A1 (fr) * 1998-07-27 2000-02-10 Connaught Laboratories Limited Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
CA2366462C (fr) * 1998-12-04 2011-08-09 University Of Manitoba Procedure d'immunisation en deux etapes contre l'infection parchlamydia
ATE463575T1 (de) * 1999-12-22 2010-04-15 Aventis Pasteur Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
AU2138601A (en) * 1999-12-22 2001-07-03 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2001046225A2 (fr) * 1999-12-22 2001-06-28 Aventis Pasteur Limited Antigenes anti-chlamydia, fragments d'adn correspondants et leurs utilisations
ES2386386T3 (es) * 2001-12-12 2012-08-20 Novartis Vaccines And Diagnostics S.R.L. Inmunización contra Chlamydia trachomatis
ES2788728T3 (es) 2010-05-28 2020-10-22 Spixia Biotechnology Ab Antígeno de la MOMP quimérica, método y uso
US10688171B2 (en) 2015-02-10 2020-06-23 Ohio State Innovation Foundation Chlamydia-activated B cell platforms and methods thereof
CN108367058A (zh) * 2015-11-10 2018-08-03 俄亥俄州创新基金会 与加快的体液亲和力相关的方法和组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271146A (en) * 1979-09-06 1981-06-02 Seawell Albert C Methods of using Chlamydia vaccine for preventing and treating bovine and ovine diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
INFECTION AND IMMUNITY VOL 58 NO 9 1990 TAN ET AL PP3101-08 *

Also Published As

Publication number Publication date
BR9407986A (pt) 1996-12-03
WO1995012411A1 (fr) 1995-05-11
AU1129795A (en) 1995-05-23
EP0726775A4 (fr) 1999-03-31
CA2175081A1 (fr) 1995-05-11
EP0726775A1 (fr) 1996-08-21
NZ276874A (en) 1997-11-24
CN1134112A (zh) 1996-10-23

Similar Documents

Publication Publication Date Title
Martinez et al. Protection of goats against heartwater acquired by immunisation with inactivated elementary bodies of Cowdria ruminantium
CA1303988C (fr) Substances immunogenes derivees d'eimeria acervulina
JP5149242B2 (ja) Ｉｎｖａｐｌｅｘワクチンを用いた免疫化により誘導される異種保護
AU701247B2 (en) Vaccine and method for treatment of chlamydial infections
Adamus et al. Protection against keratoconjunctivitis shigellosa induced by immunization with outer membrane proteins of Shigella spp
Munir et al. Outer membrane proteins of Brucella abortus vaccinal and field strains and their immune response in buffaloes
MISHIMA et al. Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1
Prescott et al. Use of a virulence‐associated protein based enzyme‐linked immunosorbent assay for Rhodococcus equi serology in horses
Campos et al. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate.
Fiske et al. Method for reducing endotoxin in Moraxella catarrhalis UspA2 protein preparations
Champion et al. Immunization with Treponema pallidum endoflagella alters the course of experimental rabbit syphilis
EP0283840A2 (fr) Antigène de mycoplasma hyopneumoniae et ses utilisations
AU2002314793A1 (en) Heterologous protection induced by immunization with invaplex vaccine
Blanco et al. The antigenic interrelationship between the endoflagella of Treponema phagedenis biotype Reiter and Treponema pallidum Nichols strain. I. Treponemicidal activity of cross-reactive endoflagellar antibodies against T. pallidum.
Sandbulte et al. Evaluation of Chlamydia psittaci subfraction and subunit preparations for their protective capacities
US5252328A (en) Mycoplasma hyopneumoniae antigen and uses therefor
HELTING et al. SEROTYPE DETERMINANT PROTEIN OF NEISSERIA MENINGITIDIS: Large Scale Preparation by Direct Detergent Treatment of the Bacterial Cells
Anacker et al. Biological properties of rabbit antibodies to a surface antigen of Rickettsia rickettsii
AU2917892A (en) Recombinant vaccine against lyme disease
US6790446B2 (en) Campylobacter vaccine
PEREZ et al. Characterization of variable immunodominant antigens of Cowdria ruminantium by ELISA and immunoblots
Nagy et al. Iscom (Immunostimulating Complex) Vaccines Containing Mono‐or Polyvalent Pili of Enterotoxigenic E. coli; Immune Response of Rabbit and Swine
US9764017B2 (en) Potomac horse fever isolates
Saunders et al. Humoral response of the mouse to Treponema pallidum.
Lukáčová et al. Characterization and protective effect of a 29 kDa protein isolated from Coxiella burnetii by detergent Empigen BB

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired